| Literature DB >> 24583008 |
Claire M Robinson1, Michael Ohh2.
Abstract
Loss of von Hippel-Lindau protein (pVHL) is known to contribute to the initiation and progression of tumours associated with VHL disease as well as certain sporadic tumours including clear cell renal cell carcinoma (ccRCC). The VHL gene was first identified and cloned over 20 years ago and our understanding of its functions and effects has significantly increased since then. The best-known function of pVHL is its role in promoting the degradation of hypoxia-inducible factor α subunit (HIFα) as part of an E3 ubiquitin ligase complex. HIF stabilisation and transcriptional activation are also associated with various epigenetic alterations, indicating a potential role for VHL loss with changes in the epigenome. This review will highlight current knowledge regarding pVHL as well as discuss potentially novel roles of pVHL and how these may impact on cancer progression.Entities:
Keywords: Clear-cell renal cell carcinoma (ccRCC); Epigenetics; Hypoxia-inducible factor (HIF); von Hippel–Lindau protein (pVHL)
Mesh：
Substances：
Year: 2014 PMID： 24583008 DOI： 10.1016/j.febslet.2014.02.026
Source DB: PubMed Journal: FEBS Lett ISSN： 0014-5793 Impact factor: 4.124